-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
<>/* Style Definitions */ span.
"Joel's deep understanding of the biopharmaceutical industry, especially his successful experience in business transaction negotiation and alliance management, will play an important role in the future growth of Boosin's global business
"Boosin has the key technology platform and team to advance the rapid development of its innovative pipeline, and is committed to developing innovative medicines to fulfill unmet clinical needs
During his 13-year tenure at Ionis Pharmaceuticals, he brought more than $3.
"We are very pleased that Mr.
Joel Edwards has joined the company's management team at a critical stage in our continued expansion of global business development and alliance cooperation," said Dr.
Chen Mingjiu
.
"Joel's deep understanding of the biopharmaceutical industry, especially his successful experience in business transaction negotiation and alliance management, will play an important role in the future growth of Boosin's global business
"I look forward to working with the company's management team to realize the company's vision of bringing innovative breakthrough therapies to patients around the world by building alliances with global biotechnology and pharmaceutical companies," said Mr.
Joel Edwards
.
"Boosin has the key technology platform and team to advance the rapid development of its innovative pipeline, and is committed to developing innovative medicines to fulfill unmet clinical needs
Mr.
Edwards has nearly 25 years of extensive pharmaceutical industry experience in business development, alliance management, and corporate development
.
During his 13-year tenure at Ionis Pharmaceuticals, he brought more than $3.